II Clinic of Orthopaedic and Traumatology, Istituto Ortopedico Rizzoli, University of Bologna, Via GC Pupilli 1, 40136 Bologna, Italy.
Injury. 2010 Nov;41(11):1196-203. doi: 10.1016/j.injury.2010.09.028. Epub 2010 Oct 8.
The aims of this study are to describe evolution in cartilage repair from open field autologous chondrocyte implantation to regeneration by arthroscopic bone-marrow-derived cells (BMDCs) "one step" technique; to present the results of a series of patients consecutively treated and to compare in detail the different techniques used in order to establish the advantages obtained with the evolution in cartilage regenerative methods. 81 patients (mean age 30±8 years) were evaluated in this study. Patient assessment included clinical AOFAS score, X-rays and MRI preoperatively and at different established follow-ups. All the lesions were >1.5 cm(2) and received open autologous chondrocyte implantation (10 cases), arthroscopic autologous chondrocyte implantation (46 cases), and "one step" arthroscopic repair by BMDC transplantation (25 cases). For arthroscopic repair techniques a hyaluronic acid membrane was used to support cells and specifically designed instrumentation was developed. Patients of all the three groups underwent a second arthroscopy with a bioptic cartilage harvest at 1 year follow-up. Mean AOFAS score before surgery was 57.1±17.2 and 92.6±10.5 (P<0.0005) at mean 59.5±26.5 months. A similar pattern of AOFAS improvement in results was found in the three different techniques. Histological evaluations highlighted collagen type II and proteoglycan expression. The cartilage repair techniques described were able to provide a repair tissue which closely approximates the characteristics of the naive hyaline cartilage. Evolution in surgical technique, new biomaterials and more recently the use of BMDCs permitted a marked reduction in procedure morbidity and costs up to a "one step" technique able to overcome all the drawbacks of previous repair techniques.
本研究旨在描述从开放式自体软骨细胞植入到关节镜下骨髓源性细胞(BMDC)“一步法”再生的软骨修复演变过程;介绍一系列连续治疗的患者结果,并详细比较不同技术,以确定软骨再生方法演变带来的优势。本研究评估了 81 例患者(平均年龄 30±8 岁)。患者评估包括术前和不同既定随访时的临床 AOFAS 评分、X 射线和 MRI。所有病变均>1.5cm²,接受开放式自体软骨细胞植入(10 例)、关节镜下自体软骨细胞植入(46 例)和“一步法”关节镜下 BMDC 移植修复(25 例)。对于关节镜修复技术,使用透明质酸膜来支持细胞,并开发了专门设计的仪器。所有三组患者均在 1 年随访时进行第二次关节镜检查和活检软骨采集。术前平均 AOFAS 评分为 57.1±17.2,术后 59.5±26.5 个月时平均为 92.6±10.5(P<0.0005)。三种不同技术均发现 AOFAS 评分改善的相似模式。组织学评估突出了 II 型胶原和蛋白聚糖的表达。所描述的软骨修复技术能够提供一种接近原始透明软骨特征的修复组织。手术技术、新型生物材料的演变,以及最近 BMDC 的使用,使手术发病率和成本显著降低,达到“一步法”技术,能够克服以前修复技术的所有缺点。